Pfizer Submits Data for COVID-19 Vaccine in Children 5 to 11

Pfizer Submits Data for COVID-19 Vaccine in Children 5 to 11
Pfizer COVID-19 vaccines are seen kept on the table at the Christine E. Lynn Rehabilitation Center in Miami, Fla., on April 15, 2021. Chandan Khanna/AFP via Getty Images
Zachary Stieber
Updated:

Pfizer and its German partner on Tuesday said they submitted data concerning results of a COVID-19 vaccine trial in children as young as 5.

Pfizer and BioNTech sent the data to the U.S. Food and Drug Administration (FDA).

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics